rss
Tob Control 13:ii118-ii124 doi:10.1136/tc.2004.009001
  • Research paper

ARTIST (Asian regional tobacco industry scientist team): Philip Morris’ attempt to exert a scientific and regulatory agenda on Asia

  1. E K Tong1,
  2. S A Glantz2
  1. 1Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA
  2. 2Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California, USA
  1. Correspondence to:
 Stanton A Glantz PhD
 Box 1390, University of California, San Francisco, San Francisco, CA 94143–1390, USA; glantzmedicine.ucsf.edu

    Abstract

    Objective: To describe how the transnational tobacco industry has collaborated with local Asian tobacco monopolies and companies to promote a scientific and regulatory agenda.

    Methods: Analysis of previously secret tobacco industry documents.

    Results: Transnational tobacco companies began aggressively entering the Asia market in the 1980s, and the current tobacco industry in Asia is a mix of transnational and local monopolies or private companies. Tobacco industry documents demonstrate that, in 1996, Philip Morris led an organisation of scientific representatives from different tobacco companies called the Asian Regional Tobacco Industry Science Team (ARTIST), whose membership grew to include monopolies from Korea, China, Thailand, and Taiwan and a company from Indonesia. ARTIST was initially a vehicle for PM’s strategies against anticipated calls for global smoke-free areas from a World Health Organization secondhand smoke study. ARTIST evolved through 2001 into a forum to present scientific and regulatory issues faced primarily by Philip Morris and other transnational tobacco companies. Philip Morris’ goal for the organisation became to reach the external scientific and public health community and regulators in Asia.

    Conclusion: The Asian tobacco industry has changed from an environment of invasion by transnational tobacco companies to an environment of participation with Philip Morris’ initiated activities. With this participation, tobacco control efforts in Asia face new challenges as Philip Morris promotes and integrates its scientific and regulatory agenda into the local Asian tobacco industry. As the local Asian tobacco monopolies and companies can have direct links with their governments, future implementation of effective tobacco control may be at odds with national priorities.

    Footnotes

    • This work was supported by NRSA 1-T32-HP 19025 and NCI grant CA-87472.

    • No competing interests are declared by the authors. Ethics committee approval was not applicable to this analysis.

    Free sample

    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Tobacco Control.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.


    This insightful video is produced by Cancer Research UK

    Navigate This Article